This post is the fifth in our five-part series, Navigating Life Sciences Transactions, where our team of attorneys provides essential strategies and insights for successful life sciences transactions.
The life sciences industry represents a massive and highly nuanced opportunity for startups. Pharma alone is projected to cross $1.6 trillion by 2030, and healthcare AI is growing at a CAGR of over 40 ...
The Delaware Supreme Court’s Jan. 12, 2026, decision in Johnson & Johnson v. Fortis Advisors provides important insights for buyers who use earnouts in structuring their acquisitions, a common ...
Hosted on MSN
Anime that teaches life and science
Anime isn’t just entertainment — it can teach science, spark self-reflection, and inspire personal growth. From Dr. Stone’s STEM adventures to Frieren’s emotional journey, these stories blend learning ...
Real-time batch monitoring powered by machine learning is helping manufacturers detect deviations early to reduce failures, improve consistency and cut costs. By simulating cell and gene therapy ...
The Entrepreneurship and Innovation in the Life Sciences (EILS) course focuses on the role of individuals in creating, engaging with, operating or investing in new life sciences ventures. The course ...
The Board on Life Sciences (BLS) was established in 1984 to serve as the focal point for addressing critical, emerging policy and technical issues associated with the life sciences and biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results